Who makes OD dual-release Hydrocortisone?

OD dual-release Hydrocortisone is developed by Vastra Gotaland Region.

What development phase is OD dual-release Hydrocortisone in?

OD dual-release Hydrocortisone is in Phase 1.

Last reviewed 2026-05-15 · How we verify

OD dual-release Hydrocortisone

Vastra Gotaland Region · Phase 1 active Small molecule

At a glance

Generic name	OD dual-release Hydrocortisone
Also known as	Once-daily dual-release hydrocortisone
Sponsor	Vastra Gotaland Region
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Treatment Study in Patients Treated With Both Insulin & Hydrocortisone (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

OD dual-release Hydrocortisone CI brief — competitive landscape report
OD dual-release Hydrocortisone updates RSS · CI watch RSS
Vastra Gotaland Region portfolio CI